Wendy Sarah Garrett

Wendy Sarah Garrett

Harvard University

H-index: 66

North America-United States

About Wendy Sarah Garrett

Wendy Sarah Garrett, With an exceptional h-index of 66 and a recent h-index of 56 (since 2020), a distinguished researcher at Harvard University, specializes in the field of microbiome, immunology, cancer, inflammatory bowel disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma

The Role of the Microbiome in the Etiopathogenesis of Colon Cancer

Protocol: Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and …

1252 AN EMPIRICAL DIETARY PATTERN ASSOCIATED WITH GUT MICROBIAL FEATURES IN RELATION TO COLORECTAL CANCER RISK

Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival …

738 MARINE OMEGA-3 FATTY ACID INTAKE, THE GUT MICROBIOME, AND THEIR INTERACTION WITH CHRONIC SYSTEMIC INFLAMMATION IN A COHORT OF ADULT MEN

Bacteria in cancer initiation, promotion and progression

Wendy Sarah Garrett Information

University

Position

___

Citations(all)

51206

Citations(since 2020)

35595

Cited By

28985

hIndex(all)

66

hIndex(since 2020)

56

i10Index(all)

106

i10Index(since 2020)

98

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Wendy Sarah Garrett Skills & Research Interests

microbiome

immunology

cancer

inflammatory bowel disease

Top articles of Wendy Sarah Garrett

Title

Journal

Author(s)

Publication Date

Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma

Clinical Microbiology and Infection

Yasutoshi Takashima

Hidetaka Kawamura

Kazuo Okadome

Satoko Ugai

Koichiro Haruki

...

2024/1/22

The Role of the Microbiome in the Etiopathogenesis of Colon Cancer

Geniver El Tekle

Natalia Andreeva

Wendy S Garrett

2024/2/12

Protocol: Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and …

BMJ Open

Mark A Hull

Pei Loo Ow

Sharon Ruddock

Tim Brend

Alexandra F Smith

...

2023

1252 AN EMPIRICAL DIETARY PATTERN ASSOCIATED WITH GUT MICROBIAL FEATURES IN RELATION TO COLORECTAL CANCER RISK

Gastroenterology

Chun-Han Lo

Raaj Mehta

Long H Nguyen

Yiqing Wang

Wenjie Ma

...

2023/5/1

Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma

Clinical & Translational Immunology

Tomotaka Ugai

Takashi Shimizu

Hidetaka Kawamura

Satoko Ugai

Yasutoshi Takashima

...

2023

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival …

BMJ open

Mark A Hull

Pei Loo Ow

Sharon Ruddock

Tim Brend

Alexandra F Smith

...

2023/11/1

738 MARINE OMEGA-3 FATTY ACID INTAKE, THE GUT MICROBIOME, AND THEIR INTERACTION WITH CHRONIC SYSTEMIC INFLAMMATION IN A COHORT OF ADULT MEN

Gastroenterology

Sunjeong Bae

Kai Wang

Jorick Bater

Wenjie Ma

Eric B Rimm

...

2023/5/1

Bacteria in cancer initiation, promotion and progression

Geniver El Tekle

Wendy S Garrett

2023/9

1245 INTERPLAY BETWEEN COFFEE INTAKE AND THE GUT MICROBIOME IN RELATION TO HOST METABOLOME

Gastroenterology

Kai Wang

Wenjie Ma

Dong Hang

Kelsey N Thompson

Eric A Franzosa

...

2023/5/1

A gut microbe increases the effect of short-and long-term physical activity on weight change

Kai Wang

Raaj S Mehta

Wenjie Ma

Long H Nguyen

Dong D Wang

...

2023/6/13

Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut

Cell Host & Microbe

Jason P Lynch

Coral González-Prieto

Analise Z Reeves

Sena Bae

Urmila Powale

...

2023/4/12

Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies

Katherine M Kennedy

Marcus C de Goffau

Maria Elisa Perez-Muñoz

Marie-Claire Arrieta

Fredrik Bäckhed

...

2023/1/26

The gut microbiome modifies the associations of short-and long-term physical activity with body weight changes

Microbiome

Kai Wang

Raaj S Mehta

Wenjie Ma

Long H Nguyen

Dong D Wang

...

2023/5/30

Engineered E. coli for the Targeted Deposition of Therapeutic Payloads to Sites of Disease

Available at SSRN 4133893

Jason Paul Lynch

Coral González-Prieto

Analise Reeves

Urmila Powale

Neha Godbole

...

2022/1/21

Health Versus Disease: The Facts in the Case of the Microbiota

Microscopy and Microanalysis

Wendy Garrett

2022/8

Methods and compositions related to targeting ffar2 and ilc3 populations for the treatment of a gastrointestinal disease

2022/1/13

Discovery of bioactive microbial gene products in inflammatory bowel disease

Nature

Yancong Zhang

Amrisha Bhosle

Sena Bae

Lauren J McIver

Gleb Pishchany

...

2022/6/23

398: THE GUT MICROBIOME MODULATES BODY WEIGHT RESPONSE TO PHYSICAL ACTIVITY

Gastroenterology

Kai Wang

Raaj S Mehta

Wenjie Ma

Long H Nguyen

Dong Wang

...

2022/5/1

Abstract B002: History of appendectomy and colorectal cancer oncidence, overall and by intratumoral fusobacterium nucleatum status

Cancer Research

Tomotaka Ugai

Hidetaka Kawamura

Yasutoshi Takashima

Kazuo Okadome

Takashi Shimizu

...

2022/12/1

Methods of treating of inflammatory bowel disease and parasite infection

2022/2/24

See List of Professors in Wendy Sarah Garrett University(Harvard University)